Data Insights

MC-150 by Chongqing Precision Biotech for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval

MC-150 is under clinical development by Chongqing Precision Biotech and currently in Phase I for Primary Mediastinal B-Cell Lymphoma. According...

Likelihood of Approval and Phase Transition Success Rate Model - MC-150 in Primary Mediastinal B-Cell Lymphoma

Data Insights

MC-150 by Chongqing Precision Biotech for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval

MC-150 is under clinical development by Chongqing Precision Biotech and currently in Phase II for B-Cell Acute Lymphocytic Leukemia (B-Cell...

Likelihood of Approval and Phase Transition Success Rate Model - MC-150 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)

Data Insights

MC-150 by Chongqing Precision Biotech for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval

MC-150 is under clinical development by Chongqing Precision Biotech and currently in Phase II for B-Cell Non-Hodgkin Lymphoma. According to...

Likelihood of Approval and Phase Transition Success Rate Model - MC-150 in B-Cell Non-Hodgkin Lymphoma

Data Insights

MC-150 by Chongqing Precision Biotech for Follicular Lymphoma: Likelihood of Approval

MC-150 is under clinical development by Chongqing Precision Biotech and currently in Phase II for Follicular Lymphoma. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - MC-150 in Follicular Lymphoma

Data Insights

MC-150 by Chongqing Precision Biotech for Mantle Cell Lymphoma: Likelihood of Approval

MC-150 is under clinical development by Chongqing Precision Biotech and currently in Phase II for Mantle Cell Lymphoma. According to...

Likelihood of Approval and Phase Transition Success Rate Model - MC-150 in Mantle Cell Lymphoma

Data Insights

MC-150 by Chongqing Precision Biotech for Diffuse Large B-Cell Lymphoma: Likelihood of Approval

MC-150 is under clinical development by Chongqing Precision Biotech and currently in Phase II for Diffuse Large B-Cell Lymphoma. According...

Likelihood of Approval and Phase Transition Success Rate Model - MC-150 in Diffuse Large B-Cell Lymphoma

Data Insights

MC-150 by Chongqing Precision Biotech for Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval

MC-150 is under clinical development by Chongqing Precision Biotech and currently in Phase II for Chronic Lymphocytic Leukemia (CLL). According...

Likelihood of Approval and Phase Transition Success Rate Model - MC-150 in Chronic Lymphocytic Leukemia (CLL)